LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 2 of total 2

Search options

  1. Article ; Online: Placental histopathology after SARS-CoV-2 infection in pregnancy: a systematic review and meta-analysis.

    Di Girolamo, Raffaella / Khalil, Asma / Alameddine, Sara / D'Angelo, Emanuela / Galliani, Carmen / Matarrelli, Barbara / Buca, Danilo / Liberati, Marco / Rizzo, Giuseppe / D'Antonio, Francesco

    American journal of obstetrics & gynecology MFM

    2021  Volume 3, Issue 6, Page(s) 100468

    Abstract: ... in pregnancies complicated by SARS-CoV-2 infection.: Data sources: MEDLINE, Embase, Google Scholar, and the Web of Science ... with healthy controls.: Conclusion: In pregnant women with SARS-CoV-2 infection, a significant proportion ... any abnormal histologic findings. The subanalyses according to maternal symptoms owing to SARS-CoV-2 infection ...

    Abstract Objective: This study aimed to report the spectrum of placental pathology findings in pregnancies complicated by SARS-CoV-2 infection.
    Data sources: MEDLINE, Embase, Google Scholar, and the Web of Science databases were searched up to August 11, 2021.
    Study eligibility criteria: Histopathologic anomalies included maternal vascular malperfusion, fetal vascular malperfusion, acute inflammatory pathology, chronic inflammatory pathology, increased perivillous fibrin, and intervillous thrombosis. Moreover, subanalyses of symptomatic women only and high-risk pregnancies were performed.
    Methods: Histopathologic analysis of the placenta included gross examination, histopathology on hematoxylin and eosin, immunohistochemistry, fluorescence in situ hybridization, quantitative reverse transcription-polymerase chain reaction on placental tissue, and transmission electron microscope. Random-effect meta-analyses were used to analyze the data.
    Results: A total of 56 studies (1008 pregnancies) were included. Maternal vascular malperfusion was reported in 30.7% of placentas (95% confidence interval, 20.3-42.1), whereas fetal vascular malperfusion was observed in 27.08 % of cases (95% confidence interval, 19.2-35.6). Acute and chronic inflammatory pathologies were reported in 22.68% (95% confidence interval, 16.9-29.0) and 25.65% (95% confidence interval, 18.4-33.6) of cases, respectively. Increased perivillous fibrin was observed in 32.7% (95% confidence interval, 24.1-42.0) of placentas undergoing histopathologic analysis, whereas intervillous thrombosis was observed in 14.6% of cases (95% confidence interval, 9.7-20.2). Other placental findings, including a basal plate with attached myometrial fibers, microscopic accretism, villous edema, increased circulating nucleated red blood cells, or membranes with hemorrhage, were reported in 37.5% of cases (95% confidence interval, 28.0-47.5), whereas only 17.5% of cases (95% confidence interval, 10.9-25.2) did not present any abnormal histologic findings. The subanalyses according to maternal symptoms owing to SARS-CoV-2 infection or the presence of a high-risk pregnancy showed a similar distribution of the different histopathologic anomalies to that reported in the main analysis. Moreover, the risk of placental histopathologic anomalies was higher when considering only case-control studies comparing women with SARS-CoV-2 infection with healthy controls.
    Conclusion: In pregnant women with SARS-CoV-2 infection, a significant proportion of placentas showed histopathologic findings, suggesting placental hypoperfusion and inflammation. Future multicenter prospective blinded studies are needed to correlate these placental lesions with pregnancy outcomes.
    MeSH term(s) COVID-19 ; Female ; Humans ; In Situ Hybridization, Fluorescence ; Multicenter Studies as Topic ; Placenta ; Pregnancy ; Pregnancy Complications, Infectious ; Pregnancy Outcome ; Prospective Studies ; SARS-CoV-2
    Language English
    Publishing date 2021-08-21
    Publishing country United States
    Document type Journal Article ; Meta-Analysis ; Review ; Systematic Review
    ISSN 2589-9333
    ISSN (online) 2589-9333
    DOI 10.1016/j.ajogmf.2021.100468
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Placental Vascular and Inflammatory Findings from Pregnancies Diagnosed with Coronavirus Disease 2019: A Systematic Review and Meta-analysis

    Hessami, Kamran / Aagaard, Kjersti M. / Castro, Eumenia C. / Arian, Sara E. / Nassr, Ahmed A. / Barrozo, Enrico R. / Seferovic, Maxim D. / Shamshirsaz, Alireza A.

    American Journal of Perinatology

    2022  Volume 39, Issue 15, Page(s) 1643–1653

    Abstract: ... with SARS-CoV-2 and 18,326 as SARS-CoV-2-negative controls, were eligible for analysis. No significant ... Consensus Group criteria in SARS-CoV-2 positive and negative pregnancies were identified. Lesions were ... of PVFD.: Key Points: No association between SARS-CoV-2 and maternal or fetal placental malperfusion ...

    Abstract We aimed to perform a meta-analysis of the literature concerning histopathologic findings in the placentas of women with SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) infection during pregnancy. Searches for articles in English included PubMed, Web of Science, Google Scholar, and reference lists (up to April 2021). Studies presenting data on placental histopathology according to the Amsterdam Consensus Group criteria in SARS-CoV-2 positive and negative pregnancies were identified. Lesions were categorized into: maternal and fetal vascular malperfusion (MVM and FVM, respectively), acute placental inflammation with maternal and fetal inflammatory response (MIR and FIR, respectively), chronic inflammatory lesions (CILs), and increased perivillous fibrin deposition (PVFD). A total of 15 studies reporting on 19,025 placentas, n  = 699 of which were derived from women who were identified as being infected with SARS-CoV-2 and 18,326 as SARS-CoV-2-negative controls, were eligible for analysis. No significant difference in incidence of MVM (odds ratio [OR]: 1.18, 95% confidence interval [CI]: 0.73–1.90), FVM (OR: 1.23, 95% CI: 0.63–2.42), MIR (OR: 0.66, 95% CI: 0.29–1.52) or FIR (OR: 0.85, 95% CI: 0.44–1.63), and CILs (OR: 0.97, 95% CI: 0.55–1.72) was found between placentae from gravida identified as being SARS-CoV-2 infected. However, placenta from gravida identified as being infected with SARS-CoV-2 were associated with significantly increased occurrence of PVFD (OR: 2.77, 95% CI: 1.06–7.27). After subgroup analyses based on clinical severity of COVID-19 infection, no significant difference was observed in terms of reported placental pathology between symptomatic or asymptomatic SARS-CoV-2 gravidae placenta. Current evidence based on the available literature suggests that the only pathologic finding in the placentae of women who are pregnant identified as having been infected with SARS-CoV-2 was an increased prevalence of PVFD.
    Key Points: No association between SARS-CoV-2 and maternal or fetal placental malperfusion. No association between SARS-CoV-2 and maternal or fetal inflammatory response. SARS-CoV-2 is associated with increased perivillous fibrin deposition in placenta.
    Keywords COVID-19 ; SARS-CoV-2 ; placenta ; pregnancy ; pathology ; meta-analysis
    Language English
    Publishing date 2022-03-03
    Publisher Thieme Medical Publishers, Inc.
    Publishing place Stuttgart ; New York
    Document type Article
    ZDB-ID 605671-4
    ISSN 1098-8785 ; 0735-1631
    ISSN (online) 1098-8785
    ISSN 0735-1631
    DOI 10.1055/a-1787-7933
    Database Thieme publisher's database

    More links

    Kategorien

To top